About Canopy Talks
Canopy Talks is a cannabis education project from Shawn Hepper, an independent cannabis educator and researcher. We translate research and real-world practice into clear materials people can actually use, with careful claim standards and no marketing theater.
Canopy Talks is the consumer brand of Verdant Canopy, a Minnesota cannabis education business. Our first product is Understanding Medical Cannabis: Foundations, a digital PDF. More guides are on the way, always framed as education, never as prescribed medical dosing or disease treatment.
Shawn’s story
Before cannabis came into the picture, Shawn was “just a guy putting in a normal working day.” The one thing that wasn’t normal was prostate cancer.
He found out about it in 2021, when he was 51. In May 2022 he had his prostate removed, and he thought the cancer was most likely gone. It came back. The recurrence turned up in November 2022 and was confirmed in March 2023. That April he started 35 rounds of radiation, which ran seven weeks, into May.
About a third of the way through radiation, he was badly fatigued but couldn’t sleep, and he had pain in his abdomen. A medicine from his radiation oncologist didn’t help and brought side effects like headaches. So the oncologist sent him to a doctor in integrative medicine. She asked if he’d ever thought about medical cannabis. He hadn’t, and he didn’t really know anything about it. She suggested starting with a tincture, the little drops you put under your tongue.
In the book, Shawn describes what happened next: a couple of drops, and a long, quiet night of sleep. He’s careful about what that means. In his words: “That’s one person’s experience. It isn’t a study, and it can’t tell you what will happen for you. What it did was get me curious.” The research on cannabis and sleep is mixed, and for insomnia the results are unclear and the evidence is very uncertain.
So he started reading research. What surprised him most was how little it took, that it’s not all about the THC, and that more isn’t always better. He learned about other cannabinoids that still need much more research, about terpenes, and about the many forms beyond smoking: tinctures, gummies, capsules, and tablets.
One thing he wants to be clear about: “Cannabis was never a treatment for my cancer. Surgery and radiation treated it, and nothing in this guide says cannabis treats cancer.”
“I’m not a doctor. I’m a prostate cancer survivor. Cannabis has been part of how I manage my own pain, sleep, and anxiety. That’s my experience, not medical advice. What works for me may not work for you, so talk with your own clinician.”
Why he wrote Foundations
Along the way, Shawn noticed how differently people see two plant-based medicines. Morphine comes from the opium poppy, and most people don’t think twice about a prescription. Cannabis still gets treated like it wears a scarlet letter. That doesn’t mean the two are equally safe. They’re not, and the book gives cannabis’s real risks a full chapter. His point is about stigma, and how it keeps people from talking openly with their care team.
In his words: “I wrote it because I want a foundation that folks can read fairly quick to get the gist of what cannabis is and how it works.” He also wants to help chip away at the stigma that Reefer Madness left behind, so people feel able to ask honest questions.
An educator and researcher, not a clinician
Shawn is not a physician, pharmacist, or other licensed clinician, and Canopy Talks doesn’t act like one. We don’t sell cannabis or cannabis products. We don’t recommend specific products, brands, or doses for anyone. What we do is read the research closely, explain it in plain words, and help you bring better questions to the people who do treat you.
That means giving the risks the same weight as the benefits, on purpose. Foundations has full chapters on drug interactions and on side effects and who should be careful, because you can’t make a good decision without both halves.
How we source information
- Published sources, numbered. Foundations has 91 numbered references, and the journal entries were checked against PubMed.
- Major reviews and official labels first. The “Where the Research Stands” ratings draw chiefly on the National Academies report (2017), Cochrane reviews, a BMJ meta-analysis (2021), a Lancet Psychiatry meta-analysis (2019), and the federal Agency for Healthcare Research and Quality (AHRQ) review on chronic pain (2025 update), plus the other sources cited in each row. Elsewhere the book also relies on FDA drug labels, the CDC, and professional medical guidance.
- A clear evidence yardstick. Large human trials, and reviews that pool many trials, count the most. Studies that follow groups of people over time come next. Animal, tissue, and cell studies count the least.
- Early findings get labeled. When a finding comes from lab or animal work, a small study, or one case, the text says so right there, and some sit in marked boxes such as “Research note” and “Case report only.”
- Funding is named. The book points out industry ties where they matter, for example on two company-run CBN sleep trials and an industry-funded expert panel on chronic pain.
- Diagrams. The diagrams are our own designs, made with help from AI image tools and matplotlib, a charting tool. None is reproduced from a published paper.
- Dated. The current edition is v1.4.3, with information current as of September 2026.
Get in touch
Questions, corrections, or a source we should look at? Email help@canopytalks.com. We can’t answer personal medical questions.